Although states decide on vaccination schedules, the inclusion of COVID-19 shots to the national recommendation means the vaccine’s fees are waived for uninsured children when federal funds run out. That day is nearing as the COVID-19 public health emergency will end in May.
For people under 18 years old, here is the recommended COVID-19 primary series:
- 6 months to 4 years old: Moderna’s two-dose series at 0 and 4-8 weeks or Pfizer’s three-dose series at 0, 3-8 and 11-16 weeks.
- 5 to 11 years old: Moderna’s two-dose series at 0 and 4-8 weeks or Pfizer’s two-dose series at 0 and 3-8 weeks.
- 12 to 18 years old: Moderna’s two-dose series at 0 and 4-8 weeks; Pfizer’s two-dose series at 0 and 3-8 weeks; or Novavax’s two-dose series at 0 and 3-8 weeks.
The recommended COVID-19 immunization schedule for adults is Moderna’s two-dose series at 0 and 4-8 weeks, Pfizer’s two-dose series at 0 and 3-8 weeks or Novavax’s two-dose series at 0 and 3-8 weeks.
There are different recommendations for special situations, such as those who are moderately or severely immunocompromised.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.